Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tilray Brands Inc
(NQ:
TLRY
)
1.320
+0.030 (+2.33%)
Streaming Delayed Price
Updated: 3:03 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Tilray Brands Inc
< Previous
1
2
3
4
5
6
7
8
9
...
89
90
Next >
Prediction: Tilray Brands Won't Be a Cannabis Company in 5 Years
November 20, 2024
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
These 2 Marijuana Stocks Could Surge Under Trump's Second Term
November 20, 2024
Via
The Motley Fool
Topics
Cannabis
Government
Exposures
Cannabis
Political
Beverages, Alcohol and Tobacco Stocks Q3 Recap: Benchmarking Tilray Brands (NASDAQ:TLRY)
November 20, 2024
Looking back on beverages, alcohol and tobacco stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Tilray Brands (NASDAQ:TLRY) and its peers.
Via
StockStory
Topics
Cannabis
Exposures
Cannabis
How Is The Market Feeling About Tilray Brands?
November 19, 2024
Via
Benzinga
Q3 Earnings Outperformers: Celsius (NASDAQ:CELH) And The Rest Of The Beverages, Alcohol and Tobacco Stocks
November 19, 2024
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Celsius (NASDAQ:CELH) and the best and worst...
Via
StockStory
Topics
Cannabis
Exposures
Cannabis
Is Tilray Brands Stock a Buy?
October 16, 2024
Tilray is beaten down, but that alone doesn't make it cheap.
Via
The Motley Fool
Shareholder Lawsuit Challenges Tilray's Voting Tactics For Authorized Share Increase
November 15, 2024
Tilray faces a new shareholder lawsuit accusing the company of misleading voting practices, following a $39.9M settlement over similar issues
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Tilray Joins German Cannabis Fiesta With First Locally Grown Strains
November 14, 2024
Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's expanding market...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
CBD Pioneer Charlotte's Web Narrows Loss In Q3, Focuses On Long-Term Growth
November 14, 2024
Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF) a producer of hemp-derived CBD and other botanical wellness products, reported on Thursday financial results for the third quarter ended Sept....
Via
Benzinga
Does the Rejection of Top Marijuana Legalization Measures Doom the Pot Industry?
November 13, 2024
The American electorate seems to have turned against weed legal reform.
Via
The Motley Fool
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis
November 12, 2024
Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Cannabis Stocks: Is It Time To Buy The Dip After Elections And Legalization Setbacks?
November 07, 2024
After a post-election plunge, cannabis stocks are showing signs of recovery. We analyze Tilray, SNDL, Trulieve, MSOS – time to buy the dip?
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?
November 07, 2024
Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Extract Significantly Reduces Chemotherapy-Induced Vomiting, Tilray-Backed Study Reveals
November 07, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
November 06, 2024
Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today.
Via
Benzinga
Topics
Cannabis
Government
Exposures
Cannabis
Political
Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty
November 06, 2024
Cannabis stocks plunge as Florida's legalization fails and GOP Senate control tempers expectations for industry growth.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Tilray, High Tide, Glass House: How Top Cannabis Companies Deal With Financial Pressures
November 01, 2024
Discover how cannabis stocks like Tilray, High Tide, and Glass House adapt strategies amid election uncertainty and market volatility.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stocks Sink Amid Broader Market Decline And Election Jitters
October 31, 2024
Cannabis stocks drop amid broader market downturn and election uncertainty, with major players like Tilray and Aurora Cannabis w/ losses.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
3 Stocks That Have Generated Terrifying Returns for Investors Over the Past 5 Years
October 31, 2024
Boo! These stocks have all lost more than half of their value in just five years.
Via
The Motley Fool
Beyond Beer, Tilray's $1.67 Billion Market Play: Is This Cannabis Giant Still A Smart Buy?
October 29, 2024
Zuanic & Associates rates Tilray "Neutral," noting long-term potential but near-term uncertainties, despite cannabis growth in Germany.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground
October 29, 2024
Amid this slowdown, certain products capture consumer interest, even as prices stabilize and competition intensifies.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
EXCLUSIVE: Tilray CEO Irwin Simon On Why US Cannabis Rescheduling Won't Change A Billion-Dollar Play
October 23, 2024
CEO Irwin Simon addressed the recent quarterly performance and challenges the company faces in both domestic and international markets.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Keurig Dr Pepper (KDP) To Report Earnings Tomorrow: Here Is What To Expect
October 23, 2024
Beverage company Keurig Dr Pepper (NASDAQ:KDP) will be reporting results tomorrow morning. Here’s what to look for.
Via
StockStory
Female Cannabis Consumers Outspend Men: How Tilray And High Tide Are Responding
October 22, 2024
Young women now lead cannabis consumption in the U.S., prompting retailers to adapt their products and strategies to meet this demand.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For October 22, 2024
October 22, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For October 22, 2024
October 22, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Billion-Dollar Cannabis And Beverage Giant Brings Oktoberfest Vibes To Your Glass With New Craft Beers
October 16, 2024
Tilray announced a series of fall-themed product launches across its craft beer and beverage brands. Those include Breckenridge Brewery, Montauk Brewing, Blue Point Brewing, Terrapin and Shock...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Tilray CEO Irwin Simon: 2024 Election Likely To Drive U.S. Cannabis Legalization, No Matter Who Wins
October 10, 2024
Tilray CEO Irwin Simon says the 2024 election is key for cannabis reform, with both presidential candidates backing legalization.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For October 10, 2024
October 10, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Tilray Brands (TLRY) Q1 2025 Earnings Call Transcript
October 10, 2024
TLRY earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
< Previous
1
2
3
4
5
6
7
8
9
...
89
90
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.